These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8758800)

  • 61. 5-fluorouracil induced cardiotoxicity: review of the literature.
    Sorrentino MF; Kim J; Foderaro AE; Truesdell AG
    Cardiol J; 2012; 19(5):453-8. PubMed ID: 23042307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.
    Polk A; Vistisen K; Vaage-Nilsen M; Nielsen DL
    BMC Pharmacol Toxicol; 2014 Sep; 15():47. PubMed ID: 25186061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Investigation of 5-fluorouracil cardiotoxicity in combinational therapy: Influence of risk factors and demographics in a Pakistani population.
    Raza H; Javaid M; Rehman W; Rafiq S; Rashid Z; Shamim R; Jaradat A; Yousif MD
    J Oncol Pharm Pract; 2024 Oct; ():10781552241275948. PubMed ID: 39360447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Emergency coronary angioplasty following treatment with 5-fluorouracil].
    Prunier F; Monségu J; Coutant G; Ollivier JP
    Rev Med Interne; 2000 May; 21(5):439-44. PubMed ID: 10874764
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiotoxicity of 5-flourouracil: two case reports.
    Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
    Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fluorouracil cardiotoxicity.
    Anand AJ
    Ann Pharmacother; 1994 Mar; 28(3):374-8. PubMed ID: 8193429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The association between systemic immune-inflammation index and cardiotoxicity related to 5-Fluorouracil in colorectal cancer.
    Liu X; Wang Y; Wang W; Dong H; Wang G; Chen W; Chen J; Chen W
    BMC Cancer; 2024 Jun; 24(1):782. PubMed ID: 38951749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil.
    Talapatra K; Rajesh I; Rajesh B; Selvamani B; Subhashini J
    J Cancer Res Ther; 2007; 3(3):169-71. PubMed ID: 18079582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug.
    Mishra T; Shokr M; Ahmed A; Afonso L
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cardiotoxicity of 5-fluorouracil: a question of formulation].
    Lemaire L; Arellano M; Malet-Martino MC; Martino R; De Forni M
    Bull Cancer; 1994 Dec; 81(12):1057-9. PubMed ID: 7742593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.
    Tsavaris N; Kosmas C; Vadiaka M; Skopelitis E; Kopteridis P; Pamouki S; Efremidis M; Kasparian H; Moisakis I; Sakelariou D; Koufos C
    J BUON; 2005; 10(2):205-11. PubMed ID: 17343330
    [TBL] [Abstract][Full Text] [Related]  

  • 73. EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS.
    Moghaddam Z; Rostami M; Zeraatchi A; Abadi H; Karamitanha F; Amirmoghaddami H
    Exp Oncol; 2022 May; 44(1):60-66. PubMed ID: 35548958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment.
    Rajaeinejad M; Parhizkar-Roudsari P; Khoshfetrat M; Kazemi-Galougahi MH; Mosaed R; Arjmand R; Mohsenizadeh SA; Arjmand B
    Cardiovasc Toxicol; 2024 Feb; 24(2):184-198. PubMed ID: 38324115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 5-Fluorouracil-associated cardiotoxicity.
    Freeman NJ; Costanza ME
    Cancer; 1988 Jan; 61(1):36-45. PubMed ID: 3275485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy].
    Rodríguez Roldán JM; Lara Alvarez MA; López Martínez J; Díaz Abad R; Caballero Campo M; Del Nogal Sáez F
    Med Intensiva; 2006 Apr; 30(3):123-4. PubMed ID: 16729482
    [No Abstract]   [Full Text] [Related]  

  • 77. Cardiotoxicity related to 5-fluorouracil chemotherapy: a report of two cases.
    Weng MC; Wang WB; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):266-9. PubMed ID: 7780886
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series.
    Jose N; Joel A; Selvakumar RJ; Ramireddy J; John AO; Georgy JT; Singh A; Ram TS
    J Egypt Natl Canc Inst; 2022 May; 34(1):22. PubMed ID: 35599280
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
    Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
    Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 5-Fluorouracil induces arterial vasocontractions.
    Südhoff T; Enderle MD; Pahlke M; Petz C; Teschendorf C; Graeven U; Schmiegel W
    Ann Oncol; 2004 Apr; 15(4):661-4. PubMed ID: 15033676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.